Cannabix TechnologiesFRA:8CT +7.14%32 Market Cap is €44.83 Mil as of Jul. 08, 2026. GuruFocus rates FRA:8CT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 867 Medical Devices & Instruments companies, Cannabix Technologies ranks worse than 62.17% on this metric.
Cannabix Technologies's quarterly market cap
declined
from Jul. 2025 (€43.83 Mil) to Oct. 2025 (€38.26 Mil) but then
increased
from Oct. 2025 (€38.26 Mil) to Jan. 2026 (€43.34 Mil).
Cannabix Technologies's annual market cap
increased
from Apr. 2023 (€21.23 Mil) to Apr. 2024 (€21.80 Mil) and
increased
from Apr. 2024 (€21.80 Mil) to Apr. 2025 (€42.24 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cannabix Technologies's Enterprise Value for Today is €44.08 Mil.
Cannabix Technologies (FRA:8CT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cannabix Technologies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Market Cap distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cannabix Technologies's Market Cap for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabix Technologies (FRA:8CT) has a Market Cap of €44.83 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabix Technologies and its competitors. According to the industry distribution chart, Cannabix Technologies ranks #539 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 62.2%.
Is Cannabix Technologies' Market Cap too high?
Cannabix Technologies' current Market Cap is €44.83 Mil. Based on the distribution chart, Cannabix Technologies ranks #539 out of 867 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Cannabix Technologies has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #539 out of 867 companies for Market Cap. This places Cannabix Technologies in the lower half of its industry. The industry median Market Cap is 121.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 121.11, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 121.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current Market Cap is €44.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (FRA:8CT) has a current Market Cap of €44.83 Mil. The current Market Cap is €44.83 Mil. Cannabix Technologies' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cannabix Technologies (FRA:8CT), the current Market Cap is €44.83 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
32GF Score
Get the complete analysis for FRA:8CT
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8CT has been successfully added to your 
